Alan Cowan

Affiliations: 
Temple University, Philadelphia, PA, United States 
Area:
Pharmacology, Neuroscience Biology
Google:
"Alan Cowan"
Mean distance: 15266.6
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Inan S, Cowan A. (2020) Antipruritic Effects of Kappa Opioid Receptor Agonists: Evidence from Rodents to Humans. Handbook of Experimental Pharmacology
Eisenstein TK, Chen X, Inan S, et al. (2020) Chemokine Receptor Antagonists in Combination with Morphine as a Novel Strategy for Opioid Dose Reduction in Pain Management. Military Medicine. 185: 130-135
Inan S, Huerta AT, Jensen LE, et al. (2019) Nalbuphine, a kappa opioid receptor agonist and mu opioid receptor antagonist attenuates pruritus, decreases IL-31, and increases IL-10 in mice with contact dermatitis. European Journal of Pharmacology. 172702
Chen X, Cowan A, Inan S, et al. (2019) Opioid-Sparing Effects of Cannabinoids on Morphine Analgesia: Participation of CB1 and CB2 Receptors. British Journal of Pharmacology
Inan S, Watson MN, Doura M, et al. (2019) Chemokine receptor antagonists enhance the antinociceptive activity of oxycodone and meperidine on incisional pain in rats. British Journal of Anaesthesia
Inan S, Eisenstein TK, Watson MN, et al. (2018) Co-Administration of Chemokine Receptor Antagonists with Morphine Potentiates Morphine's Analgesic Effect on Incisional Pain in Rats. The Journal of Pharmacology and Experimental Therapeutics
Liu JJ, Chiu YT, DiMattio KM, et al. (2018) Phosphoproteomic approach for agonist-specific signaling in mouse brains: mTOR pathway is involved in κ opioid aversion. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Lyu RM, Cowan A, Zhang Y, et al. (2018) Phoenixin: a novel brain-gut-skin peptide with multiple bioactivity. Acta Pharmacologica Sinica
Cowan A, Sarabia-Estrada R, Wilkerson G, et al. (2016) Lack of adverse effects during a target animal safety trial of extended-release buprenorphine in Fischer 344 rats. Lab Animal. 45: 28-34
Qu H, Costache MC, Inan S, et al. (2015) Local, Controlled Delivery of Local Anesthetics In Vivo from Polymer - Xerogel Composites. Pharmaceutical Research
See more...